MyFinsight
Home
Blog
About
Contact
nage: the balance sheet
Download
Download image
Prepaid expenses and
other assets
$2,029K
Inventories
$18,791K
Trade receivables,
net of allowances of...
$8,506K
Cash and cash
equivalents, including...
$64,290K
Other long-term
assets
$417K
Right-of-use assets, net
$2,361K
Intangible assets, net
$246K
Leasehold improvements
and equipment, net
$1,499K
Total current assets
$93,616K
Total assets
$98,139K
Total liabilities and
stockholders' equity
$98,139K
Total stockholders'
equity
$70,676K
Total liabilities
$27,463K
Cumulative translation
adjustments
-$9K
Accumulated deficit
-$168,660K
Additional paid-in capital
$239,266K
Operating lease
obligations, less current...
$2,077K
Deferred revenue
$2,674K
Total current
liabilities
$22,712K
Common stock, 0.001 par
value authorized...
$79K
Customer deposits
$292K
Current maturities of
finance lease...
$2K
Current maturities of
operating lease...
$976K
Accrued expenses
$8,700K
Accounts payable
$12,742K
Back
Back
Balance Sheet
source: myfinsight.com
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE)